#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Modelling of the Pharmacokinetics and Pharmacodynamics of the Low-DoseMethotrexate Treatment of Psoriasis with the Aim of Dosage Individualization


Authors: J. Grim 1;  J. Chládek 1;  M. Šimková 2;  J. Vaněčková 2;  V. Koudelková 2;  J. Martinková 1;  M. Nožičková 2
Authors‘ workplace: Ústav farmakologie Lékařské fakulty v Hradci Králové, Univerzita Karlova v Praze přednostka prof. MUDr. Jiřina Martínková, CSc. 2Klinika nemocí kožních a pohlavních, Fakultní nemocnice, Hradec Králové přednostka doc. MUDr. Marie Nožičková, CSc. 1
Published in: Čes-slov Derm, , 2002, No. 4, p. 154-162
Category:

Overview

The intent of a prospective 3-month study was to evaluate the pharmacokinetics (PK) andpharmacodynamics (PD) of low-dose methotrexate (LDMTX) in recalcitrant psoriasis en plaques. 15males and 9 females (age 31-73 years) were assigned to 2 regimens of either 2.5-2.5-2.5 mg or 5-5-5 mg oral methotrexate (MTX), given in two 12-h intervals a week. HPLC was used to analysis of MTXconcentrations in plasma and urine. The comparison of MTX minimum plasma concentrationsrevealed that the steady state is reached after a third subdose (p

Key words:
low-dose methotrexate - psoriasis - PASI score

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Dermatology & STDs Paediatric dermatology & STDs
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#